Allianz has got the deal it couldn't get two years ago. The German insurer has agreed to buy HSBC's Singapore life and health insurance business for S$2.7 billion (about $2.1 billion, £1.6 billion), giving it the foothold in one of Asia's most sought-after insurance markets that slipped through its fingers back in 2024.
Under the deal, Allianz Asia Holdings is acquiring HSBC Life (Singapore) outright from HSBC Insurance (Asia-Pacific) Holdings, with completion expected in the first half of 2027 pending sign-off from the Monetary Authority of Singapore. Alongside the sale, the two firms are locking in a 15-year exclusive bancassurance agreement, backed by an upfront S$200 million payment, under which HSBC's branches will keep selling Allianz's protection, health, retirement and wealth products to its Singapore customers.
This isn't Allianz's first run at Singapore. In 2024, the insurer walked away from a roughly S$2.2 billion bid for a majority stake in Income Insurance - the former NTUC Income - after the move drew heavy public criticism and government scrutiny over the fate of a well-known local co-operative brand. Insurance Business had already flagged Allianz as the frontrunner for the HSBC unit back in mid-June, reporting that Allianz had outbid rivals including Sumitomo Life and Daiichi Life for a business valued at up to $2 billion at the time - close to where the final price has landed.
Allianz chief executive Oliver Bäte called Singapore "central to our global growth strategy," while board member Renate Wagner said the deal lets the group aim "to support more individuals and communities even more comprehensively" across the region. Unlike the Income Insurance bid, this one involves a foreign-owned business already fully integrated into a global bank's operations - a considerably easier sell politically than taking over a homegrown mutual.
For HSBC, the disposal is another entry in chief executive Georges Elhedery's two-year push to simplify the bank, which has already seen it retreat from parts of its investment banking business across the UK, Europe and the US. The bank expects a pre-tax gain of roughly $1.8 billion on the sale and a lift of up to 15 basis points to its core capital ratio - useful ballast given profits before tax slipped slightly to $9.4 billion in HSBC's most recent quarter, weighed down by higher expected credit losses and rising costs even as revenue climbed 6% on strong wealth management performance.
HSBC Life Singapore isn't a struggling unit being offloaded at a discount, either. It posted a pre-tax profit of S$118 million in 2025. What's really going on here is HSBC trading a capital-intensive underwriting business for a capital-light distribution fee, in line with what the bank itself calls "increasing leadership and market share" only where it holds a genuine edge. In Singapore, that edge is wealth management and banking, not underwriting insurance risk.
For Allianz, absorbing HSBC Life Singapore instantly makes the city-state one of its largest life and health markets in Asia, adding to a roughly century-long regional presence that already spans eight markets and around 9 million customers. Bloomberg Intelligence analyst Steven Lam has pointed to Singapore's life insurance new business growing at least 15% this year, helped by strong wealth management demand despite a rocky start caused by market disruption earlier in 2026.
Banks now clearly value long-dated distribution deals over owning underwriting risk themselves, and this one takes that further than most. Allianz and HSBC aren't strangers here - the pair have run bancassurance partnerships across Asian markets including China, Indonesia and the Philippines for years. But folding Singapore's book directly into that relationship, rather than just distributing products, is a bigger commitment than anything the two firms have signed before.
Markets gave the deal a cautious thumbs up. HSBC's London-listed shares rose more than 1% on the news, even as its Hong Kong stock dipped slightly earlier the same day, while Allianz shares ticked up marginally in early trading.
